FSPCX | VFAIX | FSPCX / VFAIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 39 years | 21 years | - |
Gain YTD | 2.562 | 6.018 | 43% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 930M | 13.4B | 7% |
Annual Yield % from dividends | 0.89 | 1.84 | 49% |
Returns for 1 year | 9.61 | 28.97 | 33% |
Returns for 3 years | 37.15 | 31.36 | 118% |
Returns for 5 years | 46.20 | 63.95 | 72% |
Returns for 10 years | 45.85 | 155.91 | 29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BGLD | 20.10 | 0.18 | +0.90% |
FT Vest Gold Strategy Qt Buffer ETF | |||
APRW | 33.46 | -0.17 | -0.51% |
AllianzIM US Large Cap Buffer20 Apr ETF | |||
EWU | 36.36 | -0.19 | -0.52% |
iShares MSCI United Kingdom ETF | |||
BBC | 21.75 | -0.40 | -1.80% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
RSPG | 81.51 | -2.23 | -2.66% |
Invesco S&P 500® Equal Weight Energy ETF |